Alan D. Robertson

PI 3-kinase p110β: a new target for antithrombotic therapy

Shaun P. Jackson, Simone M. Schoenwaelder, Isaac Goncalves et al. · Nature Medicine · 2005 · 588 citations

Thrombosis, Medicine, Pi 3-Kinase P110β +5

The classification of prostaglandin DP‐receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist

Heather Giles, P. Leff, Mary L. Bolofo et al. · British Journal of Pharmacology · 1989 · 195 citations · Full text

Pharmacotherapy, Platelet Aggregation, Experimental Pharmacology +20

The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices

Maree T. Smith, Peter J. Cabot, F. B. Ross et al. · Pain · 2002 · 179 citations

Pain Medicine, Neuropathic Pain, Molecular Pain +16

Receptor specificity and trigemino‐vascular inhibitory actions of a novel 5‐HT_1B/1D receptor partial agonist, 311C90 (zolmitriptan)

Graeme R. Martin, Alan D. Robertson, Sara MacLennan et al. · British Journal of Pharmacology · 1997 · 101 citations · Full text

Pharmacotherapy, Experimental Pharmacology, Molecular Pharmacology +20

Some features of the autoxidation of tetralin

Alan D. Robertson, William A. Waters · Transactions of the Faraday Society · 1946 · 73 citations

Humanities, Medicine, Mechanism Of Action +4